Skip to content

Public FDA record

K183102: BOND Ready-to-Use (RTU) Primary Antibody Progesterone Receptor (16) , Novocastra Concentrated Liquid Mous

510(k) clearance K183102 for Leica Biosystems Newcastle, Limited. View source facts, labeled dates, and the original FDA record.

FDA identifier
K183102
Company in FDA record
Leica Biosystems Newcastle, Limited
FDA decision date
Dec 7, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026

Decision stated in the source

Substantially Equivalent

Source facts

Decision
Substantially Equivalent
Received
2018-11-07
Specialty
Hematology
Decision code
SESE
Clearance type
Special

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗